{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:22:31Z","timestamp":1795123351739,"version":"4.10.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY23H080003"],"award-info":[{"award-number":["LY23H080003"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971991"],"award-info":[{"award-number":["81971991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Discipline Cluster of Oncology of Wenzhou Medical University of China","award":["z2-2023021"],"award-info":[{"award-number":["z2-2023021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01994-x","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:23:56Z","timestamp":1761654236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NSUN2 promotes leukemogenesis by ferritin heavy chain 1-mediated anti-ferroptosis and enhancing global protein synthesis in an m5C-dependent manner in B-acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"17","author":[{"given":"Yigang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuzhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenmeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"12","key":"1994_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/blood.2022017035","volume":"141","author":"NE Kopmar","year":"2023","unstructured":"Kopmar NE, Cassaday RD. How i prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia. Blood. 2023;141(12):1379\u201388.","journal-title":"Blood"},{"issue":"8","key":"1994_CR2","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.7150\/thno.100295","volume":"15","author":"X Qin","year":"2025","unstructured":"Qin X, Zhou K, Dong L, Yang L, Li W, Chen Z, et al. Crispr screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia. Theranostics. 2025;15(8):3234\u201356.","journal-title":"Theranostics"},{"issue":"6","key":"1994_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.","journal-title":"Blood Cancer J"},{"issue":"12","key":"1994_CR4","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1182\/blood.2021011921","volume":"139","author":"T Yasuda","year":"2022","unstructured":"Yasuda T, Sanada M, Kawazu M, Kojima S, Tsuzuki S, Ueno H, et al. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1\/2 mutations. Blood. 2022;139(12):1850\u201362.","journal-title":"Blood"},{"issue":"8","key":"1994_CR5","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1182\/bloodadvances.2025015852","volume":"9","author":"R Faramand","year":"2025","unstructured":"Faramand R, Muffly L. Humanizing CAR T-cell therapy in B-ALL. Blood Adv. 2025;9(8):1916\u20137.","journal-title":"Blood Adv"},{"issue":"11","key":"1994_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1182\/blood.2019002132","volume":"135","author":"I Aldoss","year":"2020","unstructured":"Aldoss I, Forman SJ. How i treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy. Blood. 2020;135(11):804\u201313.","journal-title":"Blood"},{"issue":"19","key":"1994_CR7","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1182\/bloodadvances.2020002408","volume":"5","author":"JH Rogers","year":"2021","unstructured":"Rogers JH, Gupta R, Reyes JM, Gundry MC, Medrano G, Guzman A, et al. Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities. Blood Adv. 2021;5(19):3876\u201390.","journal-title":"Blood Adv"},{"issue":"12","key":"1994_CR8","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1182\/bloodadvances.2019001416","volume":"4","author":"DM Moujalled","year":"2020","unstructured":"Moujalled DM, Hanna DT, Hediyeh-Zadeh S, Pomilio G, Brown L, Litalien V, et al. Cotargeting BCL-2 and MCL-1 in high-risk B-ALL. Blood Adv. 2020;4(12):2762\u20137.","journal-title":"Blood Adv"},{"issue":"16","key":"1994_CR9","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.1093\/nar\/gkz559","volume":"47","author":"L Van Haute","year":"2019","unstructured":"Van Haute L, Lee SY, McCann BJ, Powell CA, Bansal D, Vasiliauskaite L, et al. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res. 2019;47(16):8720\u201333.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1994_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-023-05646-x","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Wei R, Zhang S, Hu S, Liang X, Yang Z, et al. Nsun2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m(5)C methylation. Cell Death Dis. 2023;14(2):125.","journal-title":"Cell Death Dis"},{"issue":"22","key":"1994_CR11","doi-asserted-by":"publisher","first-page":"11807","DOI":"10.1093\/nar\/gkz1043","volume":"47","author":"C Heissenberger","year":"2019","unstructured":"Heissenberger C, Liendl L, Nagelreiter F, Gonskikh Y, Yang G, Stelzer EM, et al. Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth. Nucleic Acids Res. 2019;47(22):11807\u201325.","journal-title":"Nucleic Acids Res"},{"key":"1994_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.omtn.2020.06.004","volume":"21","author":"L Dou","year":"2020","unstructured":"Dou L, Li X, Ding H, Xu L, Xiang H. Prediction of m5C modifications in RNA sequences by combining multiple sequence features. Mol Ther Nucleic Acids. 2020;21:332\u201342.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"1994_CR13","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.7150\/thno.104441","volume":"15","author":"D Jian","year":"2025","unstructured":"Jian D, Cheng X, Qi D, Wang S, Wang C, Shi Y, et al. Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression. Theranostics. 2025;15(6):2393\u2013412.","journal-title":"Theranostics"},{"issue":"8","key":"1994_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.stem.2023.07.001","volume":"30","author":"Y Li","year":"2023","unstructured":"Li Y, Xue M, Deng X, Dong L, Nguyen LXT, Ren L, et al. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal. Cell Stem Cell. 2023;30(8):1072\u201390.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"1994_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004639","volume":"10","author":"M Okamoto","year":"2014","unstructured":"Okamoto M, Fujiwara M, Hori M, Okada K, Yazama F, Konishi H, et al. tRNA modifying enzymes, NSUN2 and METTL1, determine sensitivity to 5-fluorouracil in HeLa cells. PLoS Genet. 2014;10(9):e1004639.","journal-title":"PLoS Genet"},{"issue":"10","key":"1994_CR16","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, et al. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35(10):1782\u201398.","journal-title":"Cell Metab"},{"issue":"39","key":"1994_CR17","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","volume":"40","author":"J Su","year":"2021","unstructured":"Su J, Wu G, Ye Y, Zhang J, Zeng L, Huang X, et al. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene. 2021;40(39):5814\u201328.","journal-title":"Oncogene"},{"issue":"7","key":"1994_CR18","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.7150\/thno.104713","volume":"15","author":"X Hou","year":"2025","unstructured":"Hou X, Dong Q, Hao J, Liu M, Ning J, Tao M, et al. NSUN2-mediated m(5)c modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2\/SRSF6\/UAP1 signaling axis. Theranostics. 2025;15(7):2757\u201377.","journal-title":"Theranostics"},{"issue":"5","key":"1994_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115661","volume":"44","author":"S Li","year":"2025","unstructured":"Li S, Liu Y, Wu X, Pan M, Zhao H, Hong Y, et al. The m((5))C methyltransferase NSUN2 promotes progression of acute myeloid leukemia by regulating serine metabolism. Cell Rep. 2025;44(5):115661.","journal-title":"Cell Rep"},{"issue":"1","key":"1994_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ajh.27124","volume":"99","author":"D Shagidov","year":"2024","unstructured":"Shagidov D, Guttmann-Raviv N, Cunat S, Frech L, Giansily-Blaizot M, Ghatpande N, et al. A newly identified ferritin L-subunit variant results in increased proteasomal subunit degradation, impaired complex assembly, and severe hypoferritinemia. Am J Hematol. 2024;99(1):12\u201320.","journal-title":"Am J Hematol"},{"issue":"1","key":"1994_CR21","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1038\/s41467-024-48151-1","volume":"15","author":"F Hoelzgen","year":"2024","unstructured":"Hoelzgen F, Nguyen TTP, Klukin E, Boumaiza M, Srivastava AK, Kim EY, et al. Structural basis for the intracellular regulation of ferritin degradation. Nat Commun. 2024;15(1):3802.","journal-title":"Nat Commun"},{"issue":"5","key":"1994_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41388-023-02882-5","volume":"43","author":"M He","year":"2024","unstructured":"He M, Wang Y, Xie J, Pu J, Shen Z, Wang A, et al. M(7)g modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma. Oncogene. 2024;43(5):341\u201353.","journal-title":"Oncogene"},{"issue":"12","key":"1994_CR23","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","volume":"11","author":"N Kong","year":"2021","unstructured":"Kong N, Chen X, Feng J, Duan T, Liu S, Sun X, et al. Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B. 2021;11(12):4045\u201354.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1994_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/ejh.13183","volume":"102","author":"S Bertoli","year":"2019","unstructured":"Bertoli S, Paubelle E, Berard E, Saland E, Thomas X, Tavitian S, et al. Ferritin heavy\/light chain (FTH1\/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia. Eur J Haematol. 2019;102(2):131\u201342.","journal-title":"Eur J Haematol"},{"key":"1994_CR25","doi-asserted-by":"publisher","first-page":"1068094","DOI":"10.3389\/fonc.2022.1068094","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu L, Wei J, Wu X, Luo J, Wei H, et al. High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia. Front Oncol. 2022;12:1068094.","journal-title":"Front Oncol"},{"issue":"1","key":"1994_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40164-024-00489-4","volume":"13","author":"S Feng","year":"2024","unstructured":"Feng S, Yuan Y, Lin Z, Li M, Ye D, Shi L, et al. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. Exp Hematol Oncol. 2024;13(1):19.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"1994_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nmeth.1314","volume":"6","author":"EK Schmidt","year":"2009","unstructured":"Schmidt EK, Clavarino G, Ceppi M, Pierre P. Sunset, a nonradioactive method to monitor protein synthesis. Nat Methods. 2009;6(4):275\u20137.","journal-title":"Nat Methods"},{"issue":"D1","key":"1994_CR28","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","volume":"52","author":"MH Gislason","year":"2024","unstructured":"Gislason MH, Demircan GS, Prachar M, Furtwangler B, Schwaller J, Schoof EM, et al. Bloodspot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis. Nucleic Acids Res. 2024;52(D1):D1138\u201342.","journal-title":"Nucleic Acids Res"},{"key":"1994_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008661","volume":"6","author":"T Perova","year":"2014","unstructured":"Perova T, Grandal I, Nutter LM, Papp E, Matei IR, Beyene J, et al. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia. Sci Transl Med. 2014;6:236.","journal-title":"Sci Transl Med"},{"key":"1994_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1172\/jci.insight.140179","volume":"5","author":"JK Bailur","year":"2020","unstructured":"Bailur JK, McCachren SS, Pendleton K, Vasquez JC, Lim HS, Duffy A, et al. Risk-associated alterations in marrow T cells in pediatric leukemia. JCI Insight. 2020;5:16.","journal-title":"JCI Insight"},{"issue":"D1","key":"1994_CR31","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, et al. Cell marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47(D1):D721\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1994_CR32","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1182\/blood-2004-10-4011","volume":"105","author":"MG Song","year":"2005","unstructured":"Song MG, Gao SM, Du KM, Xu M, Yu Y, Zhou YH, et al. Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms. Blood. 2005;105(9):3714\u201321.","journal-title":"Blood"},{"key":"1994_CR33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ncomms1692","volume":"3","author":"X Zhang","year":"2012","unstructured":"Zhang X, Liu Z, Yi J, Tang H, Xing J, Yu M, et al. The tRNA methyltransferase NSun2 stabilizes p16INK(4) mRNA by methylating the 3\u2019-untranslated region of p16. Nat Commun. 2012;3:712.","journal-title":"Nat Commun"},{"key":"1994_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"issue":"1","key":"1994_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L, et al. Socs2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 2023;30(1):137\u201351.","journal-title":"Cell Death Differ"},{"issue":"52","key":"1994_CR36","doi-asserted-by":"publisher","first-page":"18134","DOI":"10.1074\/jbc.RA119.012009","volume":"295","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang Y, Zhang J, Zhang X. Nsun2 promotes cell migration through methylating autotaxin mRNA. J Biol Chem. 2020;295(52):18134\u201347.","journal-title":"J Biol Chem"},{"issue":"1","key":"1994_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13148-024-01658-2","volume":"16","author":"D Li","year":"2024","unstructured":"Li D, Yuan Y, Meng C, Lin Z, Zhao M, Shi L, et al. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax. Clin Epigenetics. 2024;16(1):48.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"1994_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1182\/blood.2021012629","volume":"139","author":"JE Messling","year":"2022","unstructured":"Messling JE, Agger K, Andersen KL, Kromer K, Kuepper HM, Lund AH, et al. Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia. Blood. 2022;139(2):245\u201355.","journal-title":"Blood"},{"issue":"18","key":"1994_CR39","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1093\/nar\/gkac817","volume":"50","author":"H Liao","year":"2022","unstructured":"Liao H, Gaur A, McConie H, Shekar A, Wang K, Chang JT, et al. Human NOP2\/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C\/D snoRNPs. Nucleic Acids Res. 2022;50(18):10695\u2013716.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1994_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12943-025-02394-8","volume":"24","author":"W Ye","year":"2025","unstructured":"Ye W, Zhao Y, Zhou Y, Huang J, He X, Ma Z, et al. NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis. Mol Cancer. 2025;24(1):201.","journal-title":"Mol Cancer"},{"issue":"7679","key":"1994_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551(7679):247\u201350.","journal-title":"Nature"},{"issue":"7664","key":"1994_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137.","journal-title":"Nature"},{"issue":"8","key":"1994_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/dna.2021.1145","volume":"41","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ai Z, Zhang Z, Dong R, Wang L, Jin S, et al. Dihydroartemisinin triggers ferroptosis in multidrug-resistant leukemia cells. DNA Cell Biol. 2022;41(8):705\u201315.","journal-title":"DNA Cell Biol"},{"issue":"11","key":"1994_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114885","volume":"43","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang Y, Li R, Li Y, Wang Q, Wang Y, et al. STUB1-mediated ubiquitination and degradation of NSUN2 promotes hepatocyte ferroptosis by decreasing m(5)c methylation of Gpx4 mRNA. Cell Rep. 2024;43(11):114885.","journal-title":"Cell Rep"},{"key":"1994_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102975","volume":"69","author":"SJ Chen","year":"2024","unstructured":"Chen SJ, Zhang J, Zhou T, Rao SS, Li Q, Xiao LY, et al. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)C modification of SLC7A11 mRNA. Redox Biol. 2024;69:102975.","journal-title":"Redox Biol"},{"issue":"2","key":"1994_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3324\/haematol.2022.280786","volume":"108","author":"ME Lalonde","year":"2023","unstructured":"Lalonde ME, Sasseville M, Gelinas AM, Milanese JS, Beland K, Drouin S, et al. Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia. Haematologica. 2023;108(2):382\u201393.","journal-title":"Haematologica"},{"key":"1994_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102408","volume":"55","author":"LB Pontel","year":"2022","unstructured":"Pontel LB, Bueno-Costa A, Morellato AE, Carvalho Santos J, Roue G, Esteller M. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing. Redox Biol. 2022;55:102408.","journal-title":"Redox Biol"},{"issue":"2","key":"1994_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3835(01)00674-7","volume":"173","author":"G Agatha","year":"2001","unstructured":"Agatha G, Hafer R, Zintl F. Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. Cancer Lett. 2001;173(2):139\u201344.","journal-title":"Cancer Lett"},{"issue":"2","key":"1994_CR49","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cell.2018.02.048","volume":"173","author":"G Xiao","year":"2018","unstructured":"Xiao G, Chan LN, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-specific diversion of glucose carbon utilization reveals a unique vulnerability in b cell malignancies. Cell. 2018;173(2):470\u201384.","journal-title":"Cell"},{"issue":"13","key":"1994_CR50","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1158\/0008-5472.CAN-09-0112","volume":"69","author":"KH Zhang","year":"2009","unstructured":"Zhang KH, Tian HY, Gao X, Lei WW, Hu Y, Wang DM, et al. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res. 2009;69(13):5340\u20138.","journal-title":"Cancer Res"},{"issue":"4","key":"1994_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-21-0728","volume":"21","author":"J Li","year":"2022","unstructured":"Li J, Lama R, Galster SL, Inigo JR, Wu J, Chandra D, et al. Small-molecule MMRi62 induces ferroptosis and inhibits metastasis in pancreatic cancer via degradation of ferritin heavy chain and mutant p53. Mol Cancer Ther. 2022;21(4):535\u201345.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"1994_CR52","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1158\/0008-5472.CAN-10-1375","volume":"71","author":"X Liu","year":"2011","unstructured":"Liu X, Madhankumar AB, Slagle-Webb B, Sheehan JM, Surguladze N, Connor JR. Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents. Cancer Res. 2011;71(6):2240\u20139.","journal-title":"Cancer Res"},{"issue":"7","key":"1994_CR53","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.stem.2022.06.004","volume":"29","author":"C Li","year":"2022","unstructured":"Li C, Wu B, Li Y, Chen J, Ye Z, Tian X, et al. Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2alpha axis. Cell Stem Cell. 2022;29(7):1119\u201334.","journal-title":"Cell Stem Cell"},{"key":"1994_CR54","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nsmb.2357","volume":"19","author":"F Tuorto","year":"2012","unstructured":"Tuorto F, Liebers R, Musch T, Schaefer M, Hofmann S, Kellner S, et al. RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat Struct Mol Biol. 2012;19:900\u20135.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"1994_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000297","volume":"17","author":"NA Gkatza","year":"2019","unstructured":"Gkatza NA, Castro C, Harvey RF, Heiss M, Popis MC, Blanco S, et al. Cytosine-5 RNA methylation links protein synthesis to cell metabolism. PLoS Biol. 2019;17(6):e3000297.","journal-title":"PLoS Biol"},{"key":"1994_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1466","volume":"13","author":"P Li","year":"2023","unstructured":"Li P, Wang W, Zhou R, Ding Y, Li X. The m(5) C methyltransferase NSUN2 promotes codon-dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer. Clin Transl Med. 2023;13:11.","journal-title":"Clin Transl Med"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01994-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01994-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01994-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:04:23Z","timestamp":1761696263000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01994-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1994"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01994-x","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in our studies involving human participants were following the ethical standards of the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University. Informed consent for participation was signed by all patients. All animal procedures and care were conducted followed by institutional guidelines and follow national and international laws and policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"179"}}